Yomogi® Saccharomyces cerevisiae (boulardii) HANSEN CBS 5926 50 capsule pack
Yomogi® Saccharomyces cerevisiae (boulardii) HANSEN CBS 5926 20 capsule pack
General information: description of what the product is
Yomogi® contains Saccharomyces cerevisiae (boulardii) HANSEN CBS 5926 / CNCM I-745 and is classed as a probiotic yeast. This clinically validated strain, HANSEN CBS 5926 / CNCM I-745 is used in the majority of clinical and pharmacological studies to support the use of Saccharomyces cerevisiae (boulardii).
The properties and characteristics include providing relief and occurrence of diarrhoea. Yomogi® helps support healthy immune system function and can assist maintaining and supporting beneficial gut flora during antibiotic use. Yomogi® is lyophilized; therefore heat stable (no refrigeration required) and pharmaceutical grade blister sealed packaging makes Yomogi ideal for travelling.
Always read the label and patient information leaflet. Do not use if blister backing is damage or broken. If symptoms persist, talk to your healthcare professional.
Seek medical advice if diarrhoea persists for more than: 6 hours in infants under 6 months, 12 hours in children under 3 years, 24 hours in children aged 3 to 6 years or 48 hours in adults and children over 6 years. Contains Lactose
Yomogi® is used for
The active substance is the clinically validated strain Saccharomyces cerevisiae (Boulardii) HANSEN CBS 5926 / CNCM I-745 with a minimum 2.5 billion CFU (Colony Forming Units) at batch release.
Refer to the Patient Information Leaflet (PIL) for complete list of ingredients
Adults and children over 2 years of age: 1 capsule 1-2 times daily.
Children 2-6 years of age: open the hard capsule and stir the contents into food or liquid. Travellers' diarrhoea: 1 capsule 1-2 times daily starting 5 days before departure and continue for the duration of travel. Antibiotic use: 1 capsule 1-2 times daily